U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916702) titled 'A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men' on March 27.
Brief Summary: The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3031185 in healthy male subjects following administration of multiple rising doses.
Study Start Date: April 14
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI 3031185
BI 3031185
DRUG: Midazolam
Midazolam
DRUG: Placebo
Placebo matching BI 3031185
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permission from Health Da...